Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis
Anticancer Research · 2026
DOI: 10.21873/anticanres.18163 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Anticancer Research, 2026. Verfasst von Angeliki Taniskidi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Barts and the London School of Medicine, Queen Mary University of London, London, U.K. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Neoplasm Recurrence, Local, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: Borderline ovarian tumours (BOTs) frequently affect women of reproductive age. Fertility-sparing surgery (FSS) is commonly offered, but recurrence risk varies by surgical approach and histological subtype, while malignant transformation remains incompletely defined. This systematic review and meta-analysis aimed to quantify recurrence and malignant transformation risks following different surgical strategies for BOTs. MATERIALS AND METHODS: A prospectively registered protocol (PROSPERO: CRD420251172155) was followed. Studies of adult women with histologically confirmed BOTs undergoing FSS - unilateral or bilateral cystectomy, unilateral salpingo-oophorectomy (USO), or USO with contralateral cystectomy - or radical surgical staging (pelvic clearance) were included. Random-effects meta-analyses generated pooled risk estimates with 95% confidence intervals (CIs); heterogeneity was assessed using I2. Methodological quality was evaluated using MINORS. RESULTS: Forty-one studies including 5,364 women were analyzed, with follow-up ranging from 7 months to 15 years. Recurrence following FSS was highest after cystectomy-based procedures: 0.31 (95%CI=0.15-0.47; I2=97.24%) after unilateral cystectomy and 0.41 (0.26-0.57; I2=80.59%) after bilateral cystectomy. Lower recurrence was observed after USO (0.13; 0.10-0.16; I2=81.55%) and USO with contralateral cystectomy (0.31; 0.17-0.45; I2=91.40%). Radical surgery was associated with the lowest recurrence risk (0.03; 0.02-0.04; I2=26.42%). In serous BOTs, recurrence after cystectomy was 0.29 (0.23-0.56) and after USO 0.15 (0.09-0.24). In mucinous BOTs, corresponding estimates were 0.26 (0.14-0.38) and 0.08 (0.02-0.13). Overall malignant transformation occurred in 1% of women (0.01; 0.01-0.02) but increased substantially following recurrence (0.22). CONCLUSION: Cystectomy-based FSS is associated with significantly higher recurrence than oophorectomy-based approaches or radical surgery. Although malignant transformation is rare overall, its marked increase following recurrence highlights the need for histology-informed counselling and long-term, risk-adapted surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barts and the London School of Medicine, Queen Mary University of London, London, U.K.
- Royal London Hospital, Barts Health NHS Trust, London, U.K.
- University of Nicosia Medical School, Nicosia, Cyprus.
- Mater Dei Hospital, Msida, Malta.
- Centre for Cancer Screening, Prevention & Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, U.K.
- Royal London Hospital, Barts Health NHS Trust, London, U.K.; m.sideris@qmul.ac.uk.
Zitieren
APA
Taniskidi, A., Giannas, E., Lekka, S., Taniskidi, A., Lecoyte, A., Brincat, M., Dilley, J., Jeyarajah, A., Lawrence, A., Brockbank, E., Phadnis, S., Manchanda, R., & Sideris, M. (2026). Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis. Anticancer Research. https://doi.org/10.21873/anticanres.18163
Vancouver
Taniskidi A, Giannas E, Lekka S, Taniskidi A, Lecoyte A, Brincat M, et al. Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis. Anticancer Research. 2026. doi:10.21873/anticanres.18163
BibTeX
@article{Taniskidi2026,
author = {Taniskidi, Angeliki and Giannas, Evangelia and Lekka, Sofia and Taniskidi, Aikaterini and Lecoyte, Arabella and Brincat, Mark and Dilley, James and Jeyarajah, Arjun and Lawrence, Alexandra and Brockbank, Elly and Phadnis, Saurabh and Manchanda, Ranjit and Sideris, Michail},
title = {Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18163}
}
EUVIMED